Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1.

Animals Antibodies / immunology Mice Mice, Knockout Rats Rats, Sprague-Dawley Receptor, Cannabinoid, CB1 / immunology
Amino-terminus Antibody specificity Antigen retrieval CB1 receptor CB1-knockout mice Carboxy-terminus

Journal

Histochemistry and cell biology
ISSN: 1432-119X
Titre abrégé: Histochem Cell Biol
Pays: Germany
ID NLM: 9506663

Informations de publication

Date de publication:
Nov 2021
Historique:
accepted: 17 08 2021
pubmed: 29 8 2021
medline: 9 3 2022
entrez: 28 8 2021
Statut: ppublish

Résumé

Specific and selective anti-CB

Identifiants

DOI: 10.1007/s00418-021-02025-5 PMID: 34453219 PMC: PMC8604870
pubmed: 34453219
doi: 10.1007/s00418-021-02025-5
pii: 10.1007/s00418-021-02025-5
pmc: PMC8604870
doi:

Substances chimiques

Antibodies 0
Receptor, Cannabinoid, CB1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-502

Subventions

Organisme : Eusko Jaurlaritza
ID : IT1230-19
Organisme : Ministerio de Economía y Competitividad
ID : CTQ2017-85686-R
Organisme : Ministerio de Economía y Competitividad
ID : SAF2016-75292-R
Organisme : Instituto de Salud Carlos III
ID : AES 2018-PI18/00513

Informations de copyright

© 2021. The Author(s).

Références

Neuropharmacology. 2015 Apr;91:57-62
pubmed: 25484252
J Recept Signal Transduct Res. 2006;26(4):259-67
pubmed: 16818376
Neuroscience. 2012 Oct 11;222:239-68
pubmed: 22735577
Nature. 1997 Aug 21;388(6644):773-8
pubmed: 9285589
F1000Res. 2014 Oct 02;3:232
pubmed: 25324967
Eur J Pharmacol. 2000 Feb 25;390(1-2):25-36
pubmed: 10708703
Eur J Neurosci. 2008 Dec;28(12):2365-70
pubmed: 19087167
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5780-5
pubmed: 10318961
Neuropsychopharmacology. 2018 Jan;43(1):4-20
pubmed: 28862250
Elife. 2020 Dec 15;9:
pubmed: 33320083
PLoS One. 2012;7(9):e46348
pubmed: 23029489
Ann Neurol. 1989 Sep;26(3):321-30
pubmed: 2508534
Dialogues Clin Neurosci. 2020 Sep;22(3):229-239
pubmed: 33162766
Neuron. 2017 Dec 6;96(5):1112-1126.e5
pubmed: 29216450
Front Cell Neurosci. 2015 Mar 27;9:98
pubmed: 25870539
J Neurosci Methods. 2008 Jun 15;171(1):78-86
pubmed: 18406468
Neuropharmacology. 2009 Feb;56(2):455-62
pubmed: 18951909
Cereb Cortex. 2010 May;20(5):1164-74
pubmed: 19703937
J Comp Neurol. 1993 Jan 22;327(4):535-50
pubmed: 8440779
Biotechniques. 2010 Mar;48(3):197-209
pubmed: 20359301
Front Behav Neurosci. 2021 Mar 24;15:613798
pubmed: 33841106
Neuroscience. 1998 Mar;83(2):393-411
pubmed: 9460749
Synapse. 2004 Sep 1;53(3):159-67
pubmed: 15236348
F1000Res. 2017 Feb 17;6:161
pubmed: 28357047
Proc Biol Sci. 1998 Nov 7;265(1410):2081-5
pubmed: 9842734
Mol Pharmacol. 2003 Sep;64(3):570-7
pubmed: 12920192
Nat Methods. 2016 Oct;13(10):823-7
pubmed: 27595404
J Clin Invest. 2006 Apr;116(4):1005-15
pubmed: 16585965
Eur J Neurosci. 2003 Oct;18(7):1979-92
pubmed: 14622230
Trends Pharmacol Sci. 2008 Oct;29(10):528-35
pubmed: 18760490
J Neurochem. 2015 Mar;132(5):489-503
pubmed: 25308538
Neuroscience. 2003;119(2):481-96
pubmed: 12770562
Brain Res. 1980 Jan 20;182(1):1-9
pubmed: 7350980
Elife. 2020 Dec 23;9:
pubmed: 33355091
Nat Rev Neurol. 2020 Jan;16(1):9-29
pubmed: 31831863
J Comp Neurol. 2005 Dec 26;493(4):477-8
pubmed: 16304632
Adv Biol Regul. 2014 Jan;54:12-23
pubmed: 24076015
Front Neuroanat. 2021 Feb 22;15:645940
pubmed: 33692673
J Comp Neurol. 2000 Jun 26;422(2):159-71
pubmed: 10842224
Eur J Neurosci. 2000 Sep;12(9):3239-49
pubmed: 10998107
Neuroscience. 2007 Mar 2;145(1):279-87
pubmed: 17210229
PLoS One. 2013;8(1):e53082
pubmed: 23308141
Physiol Rev. 2009 Jan;89(1):309-80
pubmed: 19126760
Chem Phys Lipids. 2002 Dec 31;121(1-2):83-9
pubmed: 12505693
Science. 1999 Jan 15;283(5400):401-4
pubmed: 9888857
Brain Struct Funct. 2017 May;222(4):1897-1911
pubmed: 27678395
Cereb Cortex. 2007 Jan;17(1):175-91
pubmed: 16467563
Int J Mol Sci. 2020 Jul 17;21(14):
pubmed: 32709050
J Histochem Cytochem. 2008 Dec;56(12):1099-111
pubmed: 18796405
Bio Protoc. 2019 Jan 20;9(2):e3145
pubmed: 33654890
J Neurosci. 2006 Aug 2;26(31):8017-20
pubmed: 16885215
Histochemistry. 1981;71(2):177-86
pubmed: 7239944
J Neurosci Res. 2006 Jul;84(1):13-26
pubmed: 16615043
J Neurosci. 2005 Jul 20;25(29):6845-56
pubmed: 16033894
Mol Metab. 2014 Apr 02;3(4):495-504
pubmed: 24944910
Acta Pharmacol Sin. 2019 Mar;40(3):398-409
pubmed: 29967455
Br J Pharmacol. 2007 Nov;152(5):583-93
pubmed: 17641667
Curr Opin Struct Biol. 2006 Oct;16(5):592-9
pubmed: 16938451
Neuroscience. 2006 Jun 30;140(2):635-43
pubmed: 16563642
Nat Rev Neurosci. 2003 Nov;4(11):873-84
pubmed: 14595399
Pharmacol Ther. 2020 Apr;208:107477
pubmed: 31926199
Eur J Biochem. 2002 Aug;269(15):3771-8
pubmed: 12153574
Nat Rev Drug Discov. 2009 Apr;8(4):278
pubmed: 19348032
Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):389-95
pubmed: 18974978
Neuropharmacology. 2001 Apr;40(5):686-95
pubmed: 11311896
J Comp Neurol. 2003 Oct 13;465(2):161-3
pubmed: 12949777
Neuron. 2006 Aug 17;51(4):455-66
pubmed: 16908411
Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):385-8
pubmed: 19172248
Arch Neurol. 1968 Jul;19(1):117-20
pubmed: 5676914
Protein Eng. 1995 Jul;8(7):693-8
pubmed: 8577697
Psychopharmacology (Berl). 2001 Mar 1;154(2):115-25
pubmed: 11314673
Nature. 2015 May 21;521(7552):274-6
pubmed: 25993940
Neuroscience. 1992;48(3):655-68
pubmed: 1376455
Pharmacol Rev. 2002 Jun;54(2):161-202
pubmed: 12037135
J Neurosci Methods. 2020 May 1;337:108680
pubmed: 32145227
Eur J Biochem. 2001 Feb;268(3):499-505
pubmed: 11168387
Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):E5006-E5015
pubmed: 28584105
J Neurochem. 1973 Jul;21(1):19-40
pubmed: 4720895
PLoS One. 2007 Aug 08;2(8):e709
pubmed: 17684555
Mol Pharmacol. 2002 Jul;62(1):15-21
pubmed: 12065750
Brain Res Bull. 1982 Jun;8(6):771-4
pubmed: 6182964
Eur Neuropsychopharmacol. 2020 Jul;36:217-234
pubmed: 32057592
Eur J Neurosci. 2004 May;19(10):2682-92
pubmed: 15147302
Nature. 2002 Aug 1;418(6897):530-4
pubmed: 12152079
NIDA Res Monogr. 1991;112:129-45
pubmed: 1753996
Mol Metab. 2014 Apr 12;3(4):339
pubmed: 24944889
Life Sci. 1995;56(23-24):1983-9
pubmed: 7776822
Trends Pharmacol Sci. 1998 Sep;19(9):351-7
pubmed: 9786022
PeerJ. 2019 Feb 21;7:e6493
pubmed: 30809460
J Neurosci. 2018 Aug 1;38(31):6983-7003
pubmed: 29954847
Methods Mol Biol. 2016;1412:247-54
pubmed: 27245910
Eur J Neurosci. 1999 Dec;11(12):4213-25
pubmed: 10594647
Neuropsychopharmacology. 2020 Jan;45(2):309-318
pubmed: 31569197
J Neurochem. 2010 Aug;114(4):972-80
pubmed: 20477947
Histochemistry. 1993 Jan;99(1):91-4
pubmed: 8468197
Brain Struct Funct. 2017 Nov;222(8):3431-3452
pubmed: 28393261
Neuroscience. 2016 Dec 17;339:191-209
pubmed: 27717809
Nat Rev Drug Discov. 2018 Sep;17(9):623-639
pubmed: 30116049
Glia. 2018 Jul;66(7):1417-1431
pubmed: 29480581
J Neurosci Res. 1998 Feb 1;51(3):391-402
pubmed: 9486774
J Neurochem. 2017 Aug;142(4):521-533
pubmed: 28608535

Auteurs

Leyre Echeazarra (L)

Departament of Physiology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Bioaraba, Dispositivos Móviles para el Control de Enfermedades Crónicas, 01008, Vitoria-Gasteiz, Spain.

Gontzal García Del Caño (G)

Department of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain. gontzal.garcia@ehu.eus.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain. gontzal.garcia@ehu.eus.
ORCID: 0000-0002-7098-0986

Sergio Barrondo (S)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 28029, Madrid, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain.

Imanol González-Burguera (I)

Department of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain.

Miquel Saumell-Esnaola (M)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain.

Xabier Aretxabala (X)

Department of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.

Maider López de Jesús (M)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain.

Leire Borrega-Román (L)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain.

Susana Mato (S)

Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Achucarro Basque Center for Neuroscience, Leioa, Spain.
Multiple Sclerosis and Other Demyelinating Diseases Unit, Biocruces Bizkaia, Barakaldo, Spain.

Catherine Ledent (C)

6IRIBHN, Universite Libre de Bruxelles, Brussels, Belgium.

Carlos Matute (C)

Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain.
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Achucarro Basque Center for Neuroscience, Leioa, Spain.

María Aranzazu Goicolea (MA)

Department of Analytical Chemistry, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.

Joan Sallés (J)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain. joan.salles@ehu.eus.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 28029, Madrid, Spain. joan.salles@ehu.eus.
Bioaraba, Neurofarmacología Celular y Molecular, 01008, Vitoria-Gasteiz, Spain. joan.salles@ehu.eus.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Fit-for-purpose based testing and validation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Fit-for-purpose based testing and validation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Fit-for-purpose based testing and validation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Souris transgéniques › Souris knockout › Fit-for-purpose based testing and validation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Fit-for-purpose based testing and validation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Rat Sprague-Dawley › Fit-for-purpose based testing and validation...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Récepteurs de cannabinoïdes › Récepteur cannabinoïde de type CB1 › Fit-for-purpose based testing and validation...